Company Description
Jizhilong Holding Group is a full-chain agricultural products company focusing on the development of borneol.
Borneol is a kind of precious Chinese herbal medicine, with a variety of medicinal values and health care effects.
We are committed to maximizing the medicinal value of the borneol through scientific research and technological innovation, and to contribute to people's health and happiness.
At present, the company has established a perfect self-inspection and self-control quality management system, and the products are exported to all over the world.
At the same time, the company's well-known universities have established long-term cooperation, and the world famous experts in the field have participated in the research and development of a series of products such as borneol camphor biological extraction, and achieved a number of scientific research achievements.
| Country | United Kingdom |
| Founded | 2023 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Jing Li |
Contact Details
Address: Floor 1, Office 25 22 Market Square LONDON, E14 6BU United Kingdom | |
| Phone | +44 07706783950 |
Stock Details
| Ticker Symbol | JZL |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| CIK Code | 0001987930 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Jing Li | Chairman Of The Board |
| Xiangyou Yang | Chief Financial Officer |
| Tao Wang | Co-founder |
| Jianqun Yi | Co-founder |
| Zunsong Tang | Chief Marketing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 4, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Aug 4, 2023 | F-1 | Registration statement for certain foreign private issuers |